Basic Information
RNALocate ID: | RLID:11001957 |
RNA Symbol: | hsa-miR-186-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-186-5p |
RNA ID: | miRBase:MIMAT0000456 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001846 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001847 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001848 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001849 | Nucleus | Neural progenitor cells | 21363885 |
RLID:11001953 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001954 | Exosome | Renal cancer cells | 21670082 |
RLID:11001955 | Exosome | Breast milk | 22211110 |
RLID:11001956 | Exosome | Brain tissue | 23382797 |
RLID:11001958 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001959 | Extracellular Vesicle | Plasma | 28588009 |
RLID:11001960 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11001961 | Microvesicle | Plasma | 23077538 |
RLID:11001962 | Microvesicle | Follicular fluid | 23666971 |
RLID-D:11000101 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Tongue tissue | |
RLID-D:11000384 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-186-5p | Diffuse large b cell lymphoma | MNDR-E-MI-21154 |
MNDR | hsa-miR-186-5p | Medulloblastoma | MNDR-E-MI-21155 |
MNDR | hsa-miR-186-5p | Lymphoma | MNDR-E-MI-21156 |
MNDR | hsa-miR-186-5p | Dermatomyositis | MNDR-E-MI-21157 |
MNDR | hsa-miR-186-5p | Prostate cancer | MNDR-E-MI-21158 |
MNDR | hsa-miR-186-5p | Gastric cancer | MNDR-E-MI-21159 |
MNDR | hsa-miR-186-5p | Alzheimer disease | MNDR-E-MI-21160 |
MNDR | hsa-miR-186-5p | Intracranial aneurysm | MNDR-E-MI-21161 |
MNDR | hsa-miR-186-5p | Esophageal carcinoma | MNDR-E-MI-21162 |
MNDR | hsa-miR-186-5p | Dysautonomia familial | MNDR-E-MI-21163 |
MNDR | hsa-miR-186-5p | Polycystic ovary syndrome | MNDR-E-MI-21164 |
MNDR | hsa-miR-186-5p | Leukemia | MNDR-E-MI-21165 |
MNDR | hsa-miR-186-5p | Cardiovascular disease | MNDR-E-MI-21166 |
MNDR | hsa-miR-186-5p | Focal segmental glomerulosclerosis | MNDR-E-MI-21167 |
MNDR | hsa-miR-186-5p | Lung cancer | MNDR-E-MI-21168 |
MNDR | hsa-miR-186-5p | Down syndrome | MNDR-E-MI-21169 |
MNDR | hsa-miR-186-5p | Parkinson disease | MNDR-E-MI-21170 |
MNDR | hsa-miR-186-5p | Breast cancer | MNDR-E-MI-21171 |
MNDR | hsa-miR-186-5p | Pituitary neoplasms | MNDR-E-MI-21172 |
MNDR | hsa-miR-186-5p | Pancreatic cancer | MNDR-E-MI-21173 |
MNDR | hsa-miR-186-5p | Melanoma | MNDR-E-MI-21174 |
MNDR | hsa-miR-186-5p | Rectum adenocarcinoma | MNDR-E-MI-21175 |
MNDR | hsa-miR-186-5p | Colon cancer | MNDR-E-MI-21176 |
MNDR | hsa-miR-186-5p | Colon adenocarcinoma | MNDR-E-MI-21177 |
MNDR | hsa-miR-186-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-21178 |
MNDR | hsa-miR-186-5p | Familial ovarian cancer | MNDR-E-MI-21179 |
MNDR | hsa-miR-186-5p | Prostate adenocarcinoma | MNDR-E-MI-21180 |
MNDR | hsa-miR-186-5p | Kidney cancer | MNDR-E-MI-21181 |
MNDR | hsa-miR-186-5p | Carcinoma ductal breast | MNDR-E-MI-21182 |
MNDR | hsa-miR-186-5p | Glioblastoma | MNDR-E-MI-21183 |
MNDR | hsa-miR-186-5p | Glioma | MNDR-E-MI-21184 |
MNDR | hsa-miR-186-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-21185 |
MNDR | hsa-miR-186-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-21186 |
MNDR | hsa-miR-186-5p | Osteosarcoma | MNDR-E-MI-21187 |
MNDR | hsa-miR-186-5p | Inclusion body myositis | MNDR-E-MI-21188 |
MNDR | hsa-miR-186-5p | Meningioma | MNDR-E-MI-21189 |
MNDR | hsa-miR-186-5p | Uterine cancer | MNDR-E-MI-21190 |
MNDR | hsa-miR-186-5p | Gastric adenocarcinoma | MNDR-E-MI-21191 |
MNDR | hsa-miR-186-5p | Cervical squamous cell carcinoma | MNDR-E-MI-21192 |
MNDR | hsa-miR-186-5p | Pituitary adenoma | MNDR-E-MI-21193 |
MNDR | hsa-miR-186-5p | Lung squamous cell carcinoma | MNDR-E-MI-21194 |
MNDR | hsa-miR-186-5p | Lung adenocarcinoma | MNDR-E-MI-21195 |
MNDR | hsa-miR-186-5p | Thyroid carcinoma | MNDR-E-MI-21196 |
MNDR | hsa-miR-186-5p | Pancreatic adenocarcinoma | MNDR-E-MI-21197 |
MNDR | hsa-miR-186-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-21198 |
MNDR | hsa-miR-186-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-21199 |
MNDR | hsa-miR-186-5p | Renal clear cell carcinoma | MNDR-E-MI-21200 |
MNDR | hsa-miR-186-5p | Cholangiocarcinoma | MNDR-E-MI-21201 |
MNDR | hsa-miR-186-5p | Esophageal cancer | MNDR-E-MI-21202 |
MNDR | hsa-miR-186-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-21203 |
MNDR | hsa-miR-186-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-21204 |
MNDR | hsa-miR-186-5p | Breast invasive carcinoma | MNDR-E-MI-21205 |
MNDR | hsa-miR-186-5p | Hepatocellular carcinoma | MNDR-E-MI-21206 |
MNDR | hsa-miR-186-5p | Familiar ovarian carcinoma | MNDR-E-MI-21207 |
MNDR | hsa-miR-186-5p | B-cell lymphoma | MNDR-E-MI-21208 |
MNDR | hsa-miR-186-5p | Rheumatoid arthritis | MNDR-E-MI-21209 |
MNDR | hsa-miR-186-5p | Retinoblastoma | MNDR-E-MI-21210 |
MNDR | hsa-miR-186-5p | Hodgkin lymphoma | MNDR-E-MI-21211 |
MNDR | hsa-miR-186-5p | Tonsil cancer | MNDR-E-MI-21212 |
MNDR | hsa-miR-186-5p | Neuromyelitis optica | MNDR-E-MI-21213 |
MNDR | hsa-miR-186-5p | Skin cutaneous melanoma | MNDR-E-MI-21214 |
MNDR | hsa-miR-186-5p | Skin melanoma | MNDR-E-MI-21215 |
MNDR | hsa-miR-186-5p | Colorectal cancer | MNDR-E-MI-21216 |
MNDR | hsa-miR-186-5p | Multiple myeloma | MNDR-E-MI-21217 |
MNDR | hsa-miR-186-5p | Prostatic neoplasms | MNDR-E-MI-21218 |
MNDR | hsa-miR-186-5p | Hypersomnolence idiopathic | MNDR-E-MI-21219 |
MNDR | hsa-miR-186-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-21220 |
MNDR | hsa-miR-186-5p | Stroke lacunar | MNDR-E-MI-21221 |
MNDR | hsa-miR-186-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-21222 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCB1 | Homo sapiens | RR00022776 |
TOP